| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | vascular endothelial growth factor A | ||||
| GTO ID | GTC1402 |
| Trial ID | NCT01486771 |
| Disease | Proliferative Diabetic Retinopathy |
| Altered gene | VEGFA |
| Therapeutic/Target gene | Target gene |
| Therapy | Aptamer |
| Treatment | Macugen|pegaptanib|EYE001 |
| Phase | Phase4 |
| Recruitment status | Unknown |
| Title | A Pilot Study to Determine if Intravitreal Injections of Pegaptanib Sodium (Macugen) Given Every 12 Weeks for a Year After an Induction Phase of Three Injections Every 6 Weeks Will Reduce the Progression of Proliferative Diabetic Retinopathy in Patients Without Significant Vitreous Hemorrhage in Comparison to Treatment With Retinal Photocoagulation Alone and After an Induction Phase |
| Year | 2007 |
| Country | United States |
| Company sponsor | Valley Retina Institute |
| Other ID(s) | MPDRS-ED |
| Cohort1: Macugen | |||||||
|
|||||||
| Cohort2: Pan Retinal Photocoagulation | |||||||
|
|||||||